CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

CADTH Common Drug Review Submissions

In this section of, sponsors and publicly funded drug plans can find the documentation and resources needed to file a drug submission application to the CADTH Common Drug Review (CDR) and to manage the review process that follows.

There are also resources available for keeping current:

  • Track the status of specific drug reviews and find out about Canadian Drug Expert Committee (CDEC) recommendations. Status information on drug review listings is usually posted on every other week, reflecting status as of the end of day Wednesday (4:00 pm ET) of that week. Recommendations are posted as they are finalized.

If you represent a patient group or other stakeholder wishing to provide input into the CADTH CDR process, please refer to the section of created for that purpose. General information about the CDR is available in the About section.